leading glp-1 medications 2025 RA prescription trends: January 2019 – December As GLP-1 drugs go mainstream,

Semaglutide enhances insulin secretion in response to elevated blood glucose, suppresses glucagon release, slows gastric emptying, andcrucially for weight managementreduces appetite by acting on centres in the brain that regulate hunger and satiety

If looking to use a GLP-1 for help with weight loss, you will start with what is essentially a micro-dose: you start on the lowest .25mg dose of semaglutide and then gradually increase the dosing as tolerated, and as needed, as long as it dovetails with your weight loss goals

Glow dosing Commonly discussed at roughly 2,333 mcg of total blend injected once daily, run in shorter 4-week cycles with 2 to 4 weeks off in between

Tenascin-X deficiency in autosomal recessive EhlersDanlos syndrome